Literature DB >> 11606682

Intraoperative values of S-100 protein, myelin basic protein, lactate, and albumin in the CSF and serum of neurosurgical patients.

J de Vries1, W A Thijssen, S E Snels, T Menovsky, N G Peer, K J Lamers.   

Abstract

OBJECTIVES: To assess the concentrations of S-100 protein, myelin basic protein (MBP), and lactate, and the (CSF)/serum albumin ratio (Qalb) during intracranial neurosurgical procedures.
METHODS: Samples of CSF from 91 patients with various CNS diseases were obtained by aspiration of cisternal CSF at the beginning of surgery (before starting surgical manipulation of the brain) and concentrations of S-100 protein, MBP, and lactate, and Qalb were determined. At the same time blood was sampled for determination of serum S-100 protein concentration. Patients were divided into three groups according to the aetiology of their CNS disease (intracranial haemorrhage, n=11; benign intracranial mass lesion, n=52; malignant neoplastic disease, n=28). Radiological and intraoperative characteristics were documented.
RESULTS: In each of these three groups median values of all four CSF variables measured were raised. The occurrence of brain oedema and a midline shift correlated significantly with raised concentrations of MBP and Qalb. Breaching of the arachnoid layer, documented at surgery for benign lesions, correlated with higher concentrations of MBP, lactate, CSF S-100 protein, and Qalb.
CONCLUSIONS: Intraoperative values of S-100 protein, MBP, lactate, and Qalb are increased in patients with intracranial haemorrhage, benign intracranial mass lesion, and malignant neoplastic disease. Breaching of the arachnoid layer and oedema is associated with higher concentrations of some of the aforementioned proteins. These biochemical data can serve as a basis for further research into CSF specific proteins.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11606682      PMCID: PMC1737582          DOI: 10.1136/jnnp.71.5.671

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  15 in total

1.  Neuron-specific enolase, S-100 protein, myelin basic protein and lactate in CSF in dementia.

Authors:  P T Nooijen; H C Schoonderwaldt; R A Wevers; O R Hommes; K J Lamers
Journal:  Dement Geriatr Cogn Disord       Date:  1997 May-Jun       Impact factor: 2.959

2.  The contribution of secondary mediators to the etiology and pathophysiology of brain oedema: studies using a feline infusion oedema model.

Authors:  I R Whittle; I R Piper; J D Miller
Journal:  Acta Neurochir Suppl (Wien)       Date:  1990

3.  S-100 protein and neuron-specific enolase in cerebrospinal fluid and serum: markers of cell damage in human central nervous system.

Authors:  L Persson; H G Hårdemark; J Gustafsson; G Rundström; I Mendel-Hartvig; T Esscher; S Påhlman
Journal:  Stroke       Date:  1987 Sep-Oct       Impact factor: 7.914

4.  Myelin basic protein demonstrated immunocytochemically in oligodendroglia prior to myelin sheath formation.

Authors:  N H Sternberger; Y Itoyama; M W Kies; H D Webster
Journal:  Proc Natl Acad Sci U S A       Date:  1978-05       Impact factor: 11.205

5.  Determination of S-100 and glial fibrillary acidic protein concentrations in cerebrospinal fluid after brain infarction.

Authors:  A Aurell; L E Rosengren; B Karlsson; J E Olsson; V Zbornikova; K G Haglid
Journal:  Stroke       Date:  1991-10       Impact factor: 7.914

6.  Serum S-100 and neuron-specific enolase for prediction of regaining consciousness after global cerebral ischemia.

Authors:  P Martens; A Raabe; P Johnsson
Journal:  Stroke       Date:  1998-11       Impact factor: 7.914

7.  Observations on peritumoral oedema in meningioma. Part II: Mechanisms of oedema production.

Authors:  J M Stevens; J S Ruiz; B E Kendall
Journal:  Neuroradiology       Date:  1983       Impact factor: 2.804

8.  Age-related changes of neuron-specific enolase, S-100 protein, and myelin basic protein concentrations in cerebrospinal fluid.

Authors:  B G van Engelen; K J Lamers; F J Gabreels; R A Wevers; W J van Geel; G F Borm
Journal:  Clin Chem       Date:  1992-06       Impact factor: 8.327

9.  Cerebral oedema associated with WHO-I, WHO-II, and WHO-III-meningiomas: correlation of clinical, computed tomographic, operative and histological findings.

Authors:  J de Vries; A K Wakhloo
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216

10.  CSF myelin basic protein levels in leptomeningeal metastases. Relationship to disease activity.

Authors:  T Siegal; H Ovadia; I Yatsiv; O Abramsky
Journal:  J Neurol Sci       Date:  1987-04       Impact factor: 3.181

View more
  8 in total

Review 1.  [Neuromonitoring with S-100 protein in the intensive care unit].

Authors:  M Fries; J Bickenbach; S Beckers; D Henzler; R Rossaint; R Kuhlen
Journal:  Anaesthesist       Date:  2004-10       Impact factor: 1.041

Review 2.  Heart-fatty acid-binding protein as a marker for early detection of acute myocardial infarction and stroke.

Authors:  Pierre Lescuyer; Laure Allard; Denis F Hochstrasser; Jean-Charles Sanchez
Journal:  Mol Diagn       Date:  2005

3.  Associations among glycemic excursions, glycated hemoglobin and high-sensitivity C-reactive protein in patients with poorly controlled type 2 diabetes mellitus.

Authors:  Chun-Hong Shi; Cong Wang; Ran Bai; Xue-Yang Zhang; Li-Li Men; Jian-Ling DU
Journal:  Exp Ther Med       Date:  2015-09-04       Impact factor: 2.447

4.  Peripheral markers of brain damage and blood-brain barrier dysfunction.

Authors:  Nicola Marchi; Peter Rasmussen; Miranda Kapural; Vince Fazio; Kelly Kight; Marc R Mayberg; Andrew Kanner; Barbara Ayumar; Ben Albensi; Marco Cavaglia; Damir Janigro
Journal:  Restor Neurol Neurosci       Date:  2003       Impact factor: 2.406

5.  S-100beta protein--serum levels in children with brain neoplasms and its potential as a tumor marker.

Authors:  Anil Rajendra; Philip C Spinella; Henry R Drott; Troy E Dominguez; Leslie Sutton; Mark Helfaer
Journal:  J Neurooncol       Date:  2004-05       Impact factor: 4.130

6.  Biomarkers of Brain Damage: S100B and NSE Concentrations in Cerebrospinal Fluid--A Normative Study.

Authors:  Lenka Hajduková; Ondřej Sobek; Darina Prchalová; Zuzana Bílková; Martina Koudelková; Jiřina Lukášková; Inka Matuchová
Journal:  Biomed Res Int       Date:  2015-09-01       Impact factor: 3.411

7.  Serum myelin basic protein as a marker of brain injury in aneurysmal subarachnoid haemorrhage.

Authors:  Norbert Wąsik; Bartosz Sokół; Marcin Hołysz; Witold Mańko; Robert Juszkat; Piotr Paweł Jagodziński; Roman Jankowski
Journal:  Acta Neurochir (Wien)       Date:  2020-01-08       Impact factor: 2.216

8.  Acrylamide exposure impairs blood-cerebrospinal fluid barrier function.

Authors:  Xue Yao; Licheng Yan; Lin Yao; Weijun Guan; Fanxu Zeng; Fuyuan Cao; Yanshu Zhang
Journal:  Neural Regen Res       Date:  2014-03-01       Impact factor: 5.135

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.